Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT07313579

Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer

Led by Ukrainian Society of Clinical Oncology · Updated on 2026-01-13

200

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study investigates the outcomes of hyperthermic intraperitoneal chemoperfusion (HIPEC) in combination with curative-intent gastrectomy in resectable locally-advanced and limited-metastatic (low peritoneal cancer index) gastric cancer.

CONDITIONS

Official Title

Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 80 years
  • Histologically confirmed gastric adenocarcinoma
  • ECOG performance status of 0 or 1
  • Written informed consent to participate
  • Medically and technically operable gastric tumor
  • Tumors classified as T4a or T4b regardless of peritoneal cytology
  • Cytologically positive peritoneal washings with any T and N status
  • Adequate blood, liver, and kidney function (Hemoglobin > 120, Platelets > 150 x 10^9/L, ALT < 60, AST < 40, total bilirubin < 21 µmol/L, Creatinine clearance: males 90-140 ml/min, females 80-130 ml/min)
Not Eligible

You will not qualify if you...

  • Pregnancy or breastfeeding
  • ECOG performance status 2 to 4
  • Presence of any other malignancy
  • Hypersensitivity to mitomycin or cisplatin
  • Uncontrolled chronic diseases
  • History of allergic reactions to cisplatin or mitomycin C
  • Metastases beyond regional or peritoneal areas (e.g., liver, lungs, bone, brain, distant lymph nodes)
  • Psychiatric illness or social situations impairing compliance
  • Refusal to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Cancer Institute (NCI)

Kyiv, Ukraine

Actively Recruiting

Loading map...

Research Team

O

Oleksiy Dobrzhanskyi, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here